Literature DB >> 16879811

A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.

Aaron M D'Antona1, Kwang H Ahn, Lei Wang, Dale F Mierke, Jean Lucas-Lenard, Debra A Kendall.   

Abstract

Activation of a G-protein-coupled receptor involves changes in specific microdomain interactions within the transmembrane region of the receptor. Here, we have focused on the role of L207, proximal to the DRY motif of the human cannabinoid receptor 1 in the interconversion of the receptor resting and active states. Ligand binding analysis of the mutant receptor L207A revealed an enhanced affinity for agonists (three- to six-fold) and a diminished affinity for inverse agonists (19- to 35-fold) compared to the wild-type receptor, properties characteristic of constitutive activity. To further examine whether this mutant adopts a ligand-independent, active form, treatment with GTPgammaS was used to inhibit G protein coupling. Under these conditions, the L207A receptor exhibited a 10-fold increase in affinity for the inverse agonist SR141716A, consistent with a shift away from an enhanced precoupled state. Analysis of the cellular activity of the L207A receptor showed elevated basal cyclic AMP accumulation relative to the wild type that is inhibited by SR141716A, consistent with receptor-mediated Gs precoupling. Using toxins to selectively abrogate Gs or Gi coupling, we found that CP55940 nonetheless induced only a Gi response suggesting a strong preference of this ligand-bound form for Gi in this system. Molecular dynamics simulations reveal that the single residue change of L207A impacts the association of TM3 and TM6 in the receptor by altering hydrophobic interactions involving L207, the salt bridge involving the Arg of the DRY motif, and the helical structure of TM6, consistent with events leading to activation. The structural alterations parallel those observed in models of a mutant CB(1) receptor T210I, with established constitutive activity (D'Antona, A.M., Ahn, K.H. and Kendall, D.A., 2006. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry, 45, 5606-5617).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879811      PMCID: PMC2733829          DOI: 10.1016/j.brainres.2006.05.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  Influence of G protein type on agonist efficacy.

Authors:  Q Yang; S M Lanier
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

Review 2.  Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.

Authors:  U Gether
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.

Authors:  T J Baranski; P Herzmark; O Lichtarge; B O Gerber; J Trueheart; E C Meng; T Iiri; S P Sheikh; H R Bourne
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

5.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

6.  Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.

Authors:  A Scheer; T Costa; F Fanelli; P G De Benedetti; S Mhaouty-Kodja; L Abuin; M Nenniger-Tosato; S Cotecchia
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

7.  Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.

Authors:  M Glass; J K Northup
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

8.  G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues mediate G(i) versus G(s) activation.

Authors:  S M Wade; W K Lim; K L Lan; D A Chung; M Nanamori; R R Neubig
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

9.  Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions.

Authors:  Somnath Mukhopadhyay; Allyn C Howlett
Journal:  Mol Pharmacol       Date:  2005-03-04       Impact factor: 4.436

10.  Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.

Authors:  Sean D McAllister; Dow P Hurst; Judy Barnett-Norris; Diane Lynch; Patricia H Reggio; Mary E Abood
Journal:  J Biol Chem       Date:  2004-08-23       Impact factor: 5.157

View more
  13 in total

1.  Ligand-mimicking receptor variant discloses binding and activation mode of prolactin-releasing peptide.

Authors:  Daniel Rathmann; Diana Lindner; Stephanie H DeLuca; Kristian W Kaufmann; Jens Meiler; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

2.  Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.

Authors:  Caitlin E Scott; Ravinder Abrol; Kwang H Ahn; Debra A Kendall; William A Goddard
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

3.  Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels.

Authors:  Caitlin E Scott; Debra A Kendall
Journal:  Methods Enzymol       Date:  2017-07-05       Impact factor: 1.600

4.  Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Debra A Kendall
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

Review 5.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

6.  Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor.

Authors:  Yuxun Zhang; Zhaojun Xie; Lirong Wang; Brielle Schreiter; John S Lazo; Jurg Gertsch; Xiang-Qun Xie
Journal:  Int Immunopharmacol       Date:  2011-05-01       Impact factor: 4.932

7.  Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices.

Authors:  Kwang H Ahn; Maria Pellegrini; Natia Tsomaia; Achani K Yatawara; Debra A Kendall; Dale F Mierke
Journal:  Biopolymers       Date:  2009-07       Impact factor: 2.505

8.  Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction.

Authors:  Ankur Kapur; Patrick Samaniego; Ganesh A Thakur; Alexandros Makriyannis; Mary E Abood
Journal:  J Pharmacol Exp Ther       Date:  2008-01-03       Impact factor: 4.030

9.  Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.

Authors:  Kwang H Ahn; Caitlin E Scott; Ravinder Abrol; William A Goddard; Debra A Kendall
Journal:  Proteins       Date:  2013-06-14

10.  Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor.

Authors:  Caitlin E Scott; Kwang H Ahn; Steven T Graf; William A Goddard; Debra A Kendall; Ravinder Abrol
Journal:  J Chem Inf Model       Date:  2016-01-05       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.